Live from the NIH registry
Studies recruiting near Bonita Springs right now
Top 25 of 300 recruiting studies, sorted by proximity — each links to its official registry page
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Fort Myers, Florida (18.7 mi)
· Sponsor: AstraZeneca
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Florida Cancer Specialists & Research Institute - South — Fort Myers, Florida (18.7 mi)
· Sponsor: Revolution Medicines, Inc.
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
Advanced Solid Tumors
Phase 2
Interventional 14 participants sought
Florida Cancer Specialists - Fort Myers — Fort Myers, Florida (18.7 mi)
· Sponsor: Amgen
A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
Wet Age Related Macular Degeneration
Phase 2
Interventional 66 participants sought
Advanced Retina Institute — Bonita Springs, Florida (1.2 mi)
· Sponsor: NexThera Co., Ltd.
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy
N/A
Interventional 105 participants sought
NCH Heart Institute — Naples, Florida (14.8 mi)
· Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Endocardial Mapping With the CoreMap EP Mapping System
Persistent Atrial Fibrillation
N/A
Interventional 245 participants sought
NCH Downtown Baker Hospital — Naples, Florida (14.8 mi)
· Sponsor: CoreMap Inc.
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Florida Cancer Specialists - South ( Site 7004) — Fort Myers, Florida (18.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Hypertension, Interstitial Lung Disease
Phase 3
Interventional 344 participants sought
USA006 — Naples, Florida (14.8 mi)
· Sponsor: Insmed Incorporated
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (18.7 mi)
· Sponsor: Children's Oncology Group
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1165 — Fort Myers, Florida (18.7 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Naples, Florida (14.8 mi)
· Sponsor: TG Therapeutics, Inc.
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
Royal Palm Clinical Research — Fort Myers, Florida (18.7 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - South — Fort Myers, Florida (18.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
Florida Cancer Specialists - South ( Site 7003) — Fort Myers, Florida (18.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
N/A
Observational 350 participants sought
NCH Rooney Heart Institute — Naples, Florida (14.8 mi)
· Sponsor: Abiomed Inc.
LMN-201 for Prevention of C. Difficile Infection Recurrence
Clostridioides Difficile Infection
Phase 2, Phase 3
Interventional 375 participants sought
GI PROS Research — Naples, Florida (14.8 mi)
· Sponsor: Lumen Bioscience, Inc.
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Fort Myers, FL Investigative Site 10076 — Fort Myers, Florida (18.7 mi)
· Sponsor: Colorado Prevention Center
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — Naples, Florida (14.8 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
PARKINSON DISEASE (Disorder)
Phase 2
Interventional 80 participants sought
Vima Site #046 — Naples, Florida (14.8 mi)
· Sponsor: Vima Therapeutics
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 12 — Fort Myers, Florida (18.7 mi)
· Sponsor: Merus B.V.
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 300 participants sought
AMR Fort Myers (The Clinical Study Center) — Fort Myers, Florida (18.7 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Florida Cancer Specialists South — Fort Myers, Florida (18.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Multiple Sclerosis Spasticity
Phase 2
Interventional 200 participants sought
Aqualane Clinical Research — Naples, Florida (14.8 mi)
· Sponsor: Celgene
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
HealthPark Medical Center — Fort Myers, Florida (18.7 mi)
· Sponsor: Medtronic Cardiovascular
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Schizophrenia, Bipolar Disorder
Phase 3
Interventional 300 participants sought
Royal Palm Clinical Research — Fort Myers, Florida (18.7 mi)
· Sponsor: Intra-Cellular Therapies, Inc.